Leukotriene B4, a mediator of inflammation? 1986

S Thorsen

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007975 Leukotriene B4 The major metabolite in neutrophil polymorphonuclear leukocytes. It stimulates polymorphonuclear cell function (degranulation, formation of oxygen-centered free radicals, arachidonic acid release, and metabolism). (From Dictionary of Prostaglandins and Related Compounds, 1990) 5,12-HETE,5,12-diHETE,LTB4,Leukotriene B,Leukotriene B-4,Leukotrienes B,5,12 HETE,5,12 diHETE,B-4, Leukotriene,Leukotriene B 4
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

S Thorsen
January 1987, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
S Thorsen
March 1981, British journal of pharmacology,
S Thorsen
January 1990, Critical reviews in immunology,
S Thorsen
August 1981, Prostaglandins,
S Thorsen
November 1982, Lancet (London, England),
S Thorsen
January 2014, Expert opinion on therapeutic targets,
S Thorsen
January 1983, Agents and actions. Supplements,
S Thorsen
July 1980, The Journal of pharmacy and pharmacology,
S Thorsen
April 2024, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Copied contents to your clipboard!